[HTML][HTML] NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung cancer

A Namani, QQ Cui, Y Wu, H Wang, XJ Wang, X Tang - Oncotarget, 2017 - ncbi.nlm.nih.gov
Mutations in Kelch-like ECH-associated protein 1 (KEAP1) cause the aberrant activation of
nuclear factor erythroid-derived 2-like 2 (NRF2), which leads to oncogenesis and drug …

NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung cancer.

A Namani, QQ Cui, Y Wu, H Wang, XJ Wang, X Tang - Oncotarget, 2017 - europepmc.org
Mutations in Kelch-like ECH-associated protein 1 (KEAP1) cause the aberrant activation of
nuclear factor erythroid-derived 2-like 2 (NRF2), which leads to oncogenesis and drug …

[HTML][HTML] NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung cancer

A Namani, QQ Cui, Y Wu, H Wang, XJ Wang, X Tang - Oncotarget, 2017 - oncotarget.com
NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung
cancer | Oncotarget Online ISSN: 1949-2553 Search: Oncotarget Home Editorial Board …

NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung cancer

A Namani, QQ Cui, Y Wu, H Wang, XJ Wang… - …, 2017 - pubmed.ncbi.nlm.nih.gov
Mutations in Kelch-like ECH-associated protein 1 (KEAP1) cause the aberrant activation of
nuclear factor erythroid-derived 2-like 2 (NRF2), which leads to oncogenesis and drug …

NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung cancer

A Namani, QQ Cui, Y Wu, H Wang, XJ Wang, X Tang - Oncotarget, 2017 - oncotarget.com
NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung
cancer | Oncotarget Online ISSN: 1949-2553 Search: Oncotarget Home Editorial Board …